An importance of carbohydrate ingestion for the expression of the effect of α-glucosidase inhibitor in NIDDM

Diabetes Care

Volumn 19, Issue 6, 1996, Pages 642-647

  Hara, Tomohiro ^a   Nakamura, Jiro ^a   Koh, Naoki ^a   Sakakibara, Fumihiko ^a   Takeuchi, Naohide ^a   Hotta, Nigishi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; GLIBENCLAMIDE; INSULIN; TOLBUTAMIDE; VOGLIBOSE;

ADULT; AGED; ARTICLE; CARBOHYDRATE DIET; CIRCADIAN RHYTHM; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 0029941276     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.6.642     Document Type: Article

References (23)

1. The DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellilus. N Engl J Med 329:977-986, 1993
2. Rizza RA, Gerich JE, Haymond MW, Westland RE, Hall LD, Clemens AH, Service FJ: Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. N Engl J Med 303:1313-1318, 1980
3. Kawamori R, Bando K, Yamasaki Y, Kubota M, Watarai T, Iwata N, Shichiri M, Kamada T: Fasting plus prandial insulin supplements improve insulin secretory ability in NlDDM subjects. Diabetes Care 12:680-685, 1989
4. Puls W, Keup U, Krause HP, Thomas G, Hoffmeister F: Glucosidase inhibition: a new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia. Naturwissenschaften 64:536-537, 1977
5. Matsuo T, Odaka H, Ikeda H: Effect of an intestinal disaccharidase inhibitor (AO-128) on obesity and diabetes. Am J Clin Nutr 55:314-317, 1992
6. y. J Nutr Sci Vitaminol 38:27-37, 1992
7. Fölsch UR, Spengler M, Boehme K, Sommerauer B: Efficacy of glucosidase inhibitors compared to sulphonylureas in the treatment and metabolic control of diet treated type H diabetic subjects: two long-term comparative studies. Diab Nutr Metab 3 (Suppl. 1):63-68, 1990
8. Hanefeld M, Fischer S, Schulze J, Spengler M, Wargenau M, Schollberg K, Fücker K: Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone. Diabetes Care 14:732-737, 1991
9. Jenney A, Nankervis A, Proietto J, Traianedes K, O'Dea K, D'Embden H: Low-dose acarbose improves glycemic control in NlDDM patients without changes in insulin sensitivity. Diabetes Care 16:499-502, 1993
10. Hotta N, Kakuta H, Sano T, Matsumae H, Yamada H, Kitazawa S, Sakamoto N: Long-term effect of acarbose on glycaemic conirol in non-insulin-dependent diabetes mellitus: a placebo-controlled double-blind study. Diabetic Med 10:134-138, 1993
11. Hotta N, Kakuta H, Koh N, Sakakibara F, Haga T, Sano T, Okuyama M, Sakamoto N: The effect of acarbose on blood glucose profiles of type 2 diabetic patients receiving insulin therapy. Diabetic Med 10:355-358, 1993
12. Hoffmann J, Spengler M: Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. Diabetes Care 17:561-566, 1994
13. Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH, Wolever TMS: The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. Ann Intern Med 121:928-935, 1994
14. Coniff RF, Shapiro JA, Seaton TB, Bray GA: Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-msulin-dependent diabetes mellitus. Am J Med 98:443-451, 1995
15. Coniff RF, Shapiro JA, Robbins D, Kleinfield R, Seaton TB, Beisswenger, McGill JB: Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NlDDM: a placebo-controlled dose-comparison study. Diabetes Care 18:817-824, 1995
16. Toeller M: Dietary treatment and α-glucosidase inhibitors in NIDDM. Diabetes Nutr Metab 3 (Suppl. 1):43-49, 1990
17. Toeller M: Nutritional recommendation for diabetic patients and treatment with α-glucosidase inhibitors. Drug 44 (Suppl. 3): 13-20, 1992
18. Schlichtkrull J, Munck O, Jersild M: The M-value, an index of blood-sugar control in diabetics. Ada Med Scand 177:95-102, 1965
19. Stout RW: The impact of insulin upon atherosclerosis. Horm Metab Res 26:125-128, 1994
20. Puls W, Keup U, Krause HP, Muller L, Schmidt DD, Thomas G, Truscheit E: Pharmacology of a glucosidase inhibitor. Front Horm Res 7:235-247, 1980
21. Randle PJ, Garland PB, Hales CN, Newsholme EA, Demon RM, Pogson CI: Interactions of metabolism and the physiological role of insulin. Recent Prog Horm Res 22:1-48, 1966
22. American Diabetes Association: Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 18 (Supp. 1):16-19, 1995
23. British Diabetes Association's Medical Advisory Committee Nutrition Sub-Committee: Dietary recommendations for the 1980s: a policy statement by the British Diabetes Association. Hum Nutr Appl Nutr 36:378-386, 1982